Background illustration for clinical trials search

Paid Clinical Trials Surprise

Discover 1,294 paid clinical trials in Surprise, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,294

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

for

Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma

Location: Phoenix AZ, La Jolla CA, Irvine CA, Orange CA,

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT04031677

Phase 3, Recruiting

Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

for

Malignant Glioma

Location: Phoenix AZ, Jacksonville FL

Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05030298

Phase 1, Recruiting

Blue Light Cystoscopy With Cysview® Registry

for

Bladder Cancer

Location: Phoenix AZ, Los Angeles CA, Palo Alto CA,

Sponsor: Photocure

Sex: All

Age: 18+

Code: NCT02660645

Recruiting

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

for

Non-small Cell Lung Cancer (NSCLC)

Location: Phoenix AZ, Burbank CA, Grand Junction CO, Reno NV,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06170788

Phase 3, Recruiting

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

for

KRAS G12C Mutation, KRAS G12S Mutation,

Location: Phoenix AZ, Denver CO, Oklahoma City OK, San Antonio TX,

Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT06720987

Phase 1, Recruiting

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

for

Classic Follicular Lymphoma,

Location: Phoenix AZ, Tucson AZ, Upland CA, Irvine CA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06337318

Phase 3, Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for

Acute Myeloid Leukemia,

Location: Phoenix AZ, Tucson AZ, Irvine CA, Orange CA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05564390

Phase 2, Recruiting

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

for

Metastatic Renal Cell Carcinoma,

Location: Phoenix AZ, San Diego CA, Encinitas CA, La Jolla CA,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05327686

Phase 2, Recruiting

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

for

Solid Tumors

Location: Phoenix AZ, Irving TX, Houston TX, Rochester MN,

Sponsor: Fortvita Biologics (USA)Inc.

Sex: All

Age: 18 - 70+

Code: NCT06963281

Phase 1, Recruiting

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

for

Hematopoietic and Lymphoid Cell Neoplasm,

Location: Phoenix AZ, Kingman AZ, Henderson NV, Las Vegas NV,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 0+

Code: NCT04242095

Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for

Neoplasms

Location: Phoenix AZ, Gilbert AZ, La Jolla CA, Duarte CA,

Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase 2, Phase 3, Recruiting

Onyx™ Liquid Embolic IDE Clinical Study

for

Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer,

Location: Phoenix AZ, Irvine CA, Los Angeles CA, Aurora CO,

Sponsor: Medtronic Endovascular

Sex: All

Age: 22+

Code: NCT06742801

Recruiting

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

for

Metastatic Castration-Resistant Prostate Cancer (mCRPC),

Location: Phoenix AZ, Gilbert AZ, Tucson AZ, Santa Monica CA,

Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03972657

Phase 1, Phase 2, Recruiting

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

for

Metastatic Colorectal Adenocarcinoma,

Location: Phoenix AZ, Kingman AZ, Irvine CA, Orange CA,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT05673148

Phase 2, Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

for

Refractory Diffuse Large B Cell Lymphoma (DLBCL),

Location: Phoenix AZ, Gilbert AZ, La Jolla CA, Denver CO,

Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase 2, Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for

Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,

Location: Phoenix AZ, Scottsdale AZ, Newport Beach CA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase 2, Recruiting

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

for

Recurrent Castration-Sensitive Prostate Carcinoma,

Location: Phoenix AZ, Rochester MN, Jacksonville FL

Sponsor: Mayo Clinic

Sex: Male

Age: 18+

Code: NCT06378866

Phase 2, Recruiting

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

for

Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma

Location: Phoenix AZ, Scottsdale AZ, Kingman AZ, Henderson NV,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT05647265

Phase 2, Recruiting

Determining the Utility of a Behavioral Intervention in Chronic Migraine

for

Migraine, Headache, Migraine Disorders, Chronic Migraine,

Location: Phoenix AZ

Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05415020

Recruiting

Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors

for

Solid Tumor

Location: Phoenix AZ, Iowa City IA, Edgewood KY, Pittsburgh PA

Sponsor: Oxford BioTherapeutics Ltd

Sex: All

Age: 18+

Code: NCT04064359

Phase 1, Recruiting

Paid Clinical Trials Surprise

Filter results

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

Blue Light Cystoscopy With Cysview® Registry

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Interested in new trials?

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Onyx™ Liquid Embolic IDE Clinical Study

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

DALY II USA/ MB-CART2019.1 for DLBCL

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Determining the Utility of a Behavioral Intervention in Chronic Migraine

Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors